Esophagus Cancer Completed Phase 3 Trials for Erythropoietin (DB00016)

IndicationStatusPhase
DBCOND0032126 (Esophagus Cancer)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00270166The Effect of Epoetin Alfa on the Anemia of Patients With Selected Cancers Receiving ChemotherapyTreatment